These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Value of diuretics and aldosterone antagonists in the treatment of heart failure]. Schwinger RH Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S40-7. PubMed ID: 10535046 [No Abstract] [Full Text] [Related]
4. Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure. Teive HA; Munhoz RP; Werneck LC Mov Disord; 2007 Aug; 22(11):1678-9. PubMed ID: 17534964 [No Abstract] [Full Text] [Related]
5. Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy. Epstein M Nat Clin Pract Nephrol; 2006 Jun; 2(6):310-1. PubMed ID: 16932450 [No Abstract] [Full Text] [Related]
6. [Controlled clinical trial for the comparison of tolerance of two aldosterone antagonists]. Leizorovicz A; Guenaneche F; Luciani J; Boissel JP Therapie; 1991; 46(4):327-31. PubMed ID: 1948810 [TBL] [Abstract][Full Text] [Related]
7. Hyperkalemia after the publication of RALES. Witham MD; Gillespie ND; Struthers AD N Engl J Med; 2004 Dec; 351(23):2448-50; author reply 2448-50. PubMed ID: 15580679 [No Abstract] [Full Text] [Related]
9. Ask the doctor. I am a 50-year-old man with congestive heart failure. My doctor has me on all the usual drugs, and a couple of years ago added spironolactone. I did okay with it for a while, but then began to notice that my breasts were getting bigger and began to hurt. My doctor agreed that I should stop taking spironolactone, but I wonder if I am missing out on something. Lee TH Harv Heart Lett; 2003 Oct; 14(2):8. PubMed ID: 14576040 [No Abstract] [Full Text] [Related]
10. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481 [TBL] [Abstract][Full Text] [Related]
11. [Iatrogenic gynecomastia in aldosterone-antagonist therapy]. Quietzsch D Z Gesamte Inn Med; 1981 Feb; 36(3):87-9. PubMed ID: 7222857 [TBL] [Abstract][Full Text] [Related]
13. Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent. Lane DA; Beevers DG J Hypertens; 2007 Dec; 25(12):2515-6. PubMed ID: 17984678 [No Abstract] [Full Text] [Related]
14. Disappearance of spironolactone-induced gynecomastia with triamteren. Yamamoto S Intern Med; 2001 Jun; 40(6):550. PubMed ID: 11446686 [No Abstract] [Full Text] [Related]
15. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients. Matsumoto Y; Kageyama S; Yakushigawa T; Arihara K; Sugiyama T; Mori Y; Sugiyama H; Ohmura H; Shio N Cardiology; 2009; 114(1):32-8. PubMed ID: 19342857 [TBL] [Abstract][Full Text] [Related]
16. Two cases of male nipple leiomyoma: idiopathic leiomyoma and gynecomastia-associated leiomyoma. Nakamura S; Hashimoto Y; Takeda K; Nishi K; Ishida-Yamamoto A; Mizumoto T; Iizuka H Am J Dermatopathol; 2012 May; 34(3):287-91. PubMed ID: 22207446 [TBL] [Abstract][Full Text] [Related]